• Duphat
  • infinia camp
mededge mea logo web MedEdge_Logo_Dark

Public Relations, Top Health Magazine and Healthcare News GCC

  • Newsletters
  • Magazines
  • Subscribe
  • Home
  • News
  • Opinion
  • Interviews
  • Featured
  • Cover Stories
  • Events
  • Health For all
    • Ageing Gracefully
    • Family Health Matters
    • Environment Health
    • Women and Child Health
    • Men’s Health
  • Resource Hub
    • Fresh Perspectives
    • Medical Tourism
    • Medical Education
    • Personnel
    • Research
      • Healthcare Journals & Publishers
    • Healthcare Campaigns
    • Health Tools Hub
    • Dubai Health Centers Directory | Services, Locations & Timings
    • ME Explained
Reading: WHO adds first diagnostic test for Ebola Bundibugyo virus to its Emergency Use Listing
Share
Notification
  • Duphat
  • infinia camp
mededge mea logo web
  • Magazines
  • Newsletters
  • Profiles
  • Subscribe
Search
  • Home
  • News
  • Opinion
  • Interviews
  • Featured
  • Cover Stories
  • Events
  • Health For all
    • Ageing Gracefully
    • Family Health Matters
    • Environment Health
    • Women and Child Health
    • Men’s Health
  • Resource Hub
    • Fresh Perspectives
    • Medical Tourism
    • Medical Education
    • Personnel
    • Research
    • Healthcare Campaigns
    • Health Tools Hub
    • Dubai Health Centers Directory | Services, Locations & Timings
    • ME Explained
Have an existing account? Sign In

Home - Medical Equipment - WHO adds first diagnostic test for Ebola Bundibugyo virus to its Emergency Use Listing

Medical Equipment

WHO adds first diagnostic test for Ebola Bundibugyo virus to its Emergency Use Listing

ME Desk
ME Desk
Published: July 3, 2026
Share
3 Min Read
Untitled design 3
SHARE

The World Health Organization (WHO) has added the first molecular diagnostic test for Bundibugyo virus (BDBV) to its Emergency Use Listing (EUL). The test detects the virus by identifying its genetic material in blood samples, enabling rapid and accurate confirmation of infection.

WHOโ€™s EUL assesses the quality, safety and performance of essential health products to ensure they meet international standards while improving access to reliable diagnostics for early case detection, timely treatment, disease surveillance and outbreak response.

Click here to join our WhatsApp channel here

“Public health emergencies require not only speed, but also confidence that the health products being used meet standards for quality, safety and performance,” said Dr Yukiko Nakatani, WHO Assistant Director-General for Health Systems, Access and Data. “During a fast-moving outbreak, timely access to quality-assured diagnostic tests can make a critical difference in containing transmission. Through this Emergency Use Listing, WHO is helping countries access trusted diagnostic tools more rapidly so that they can respond more effectively.โ€

The listing comes as countries respond to the largest recorded outbreak of Ebola disease caused by Bundibugyo virus. As of today, 1,406 laboratory-confirmed cases and 438 deaths have been reported in the Democratic Republic of the Congo. WHO declared the outbreak a Public Health Emergency of International Concern on 17 May 2026, with cases also reported in Uganda.

With support from WHO and the Africa CDC, laboratory testing capacity has expanded from a few testing sites capable of 200โ€“400 tests per day to 10 laboratories across affected provinces with a capacity of more than 2,000 tests daily.

WHO continues to work with manufacturers and global partners to expand access to quality-assured diagnostic products. Additional BDBV diagnostic tests are under review, while WHO, Africa CDC and partners are also establishing a validation platform to assess molecular and rapid diagnostic tests for use during outbreaks.

Bundibugyo virus disease is a severe form of Ebola that spreads through contact with infected animals, people, bodily fluids or contaminated surfaces.

Also read: New Eye Bank to Expand Access to Corneal Transplants Across the Middle East

Share This Article
Facebook Whatsapp Whatsapp LinkedIn Copy Link
Share
Previous Article Gemini Generated Image r3v4uur3v4uur3v4 Global Health Exhibition 2026 connects 54 healthcare startups with top investors
Next Article image 11 EU Approves First Gene Replacement Therapy for Wider Spinal Muscular Atrophy Population

Recent Posts

  • ICMM Abu Dhabi 2026 Secures Strategic Partnership to Advance Military Medicine
  • EU Approves First Gene Replacement Therapy for Wider Spinal Muscular Atrophy Population
  • WHO adds first diagnostic test for Ebola Bundibugyo virus to its Emergency Use Listing
  • Global Health Exhibition 2026 connects 54 healthcare startups with top investors
  • Qatar Launches Campaign to Promote Annual Health Checkups
  • DUHAPT
  • MedEdge-Infinia
Two Point Five Logo white
  • About Us
  • Contact Us
  • Medical Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Cookie Policy (EU)
  • Submit Your Story
  • MediaKit
Reading: WHO adds first diagnostic test for Ebola Bundibugyo virus to its Emergency Use Listing
Share

Published by Two Point Five Media FZCO

  • About Us
  • Contact Us
  • Medical Disclaimer
  • Privacy Policy
  • Terms and Conditions
  • Cookie Policy (EU)
  • Submit Your Story
  • MediaKit
Reading: WHO adds first diagnostic test for Ebola Bundibugyo virus to its Emergency Use Listing
Share

Follow US on Social Media

Facebook Instagram Linkedin X-twitter Youtube Whatsapp
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}

WhatsApp us

Logo of Medede mea
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?